Business Standard - Feb. 2010

Troikaa Pharma set to get US patent

Troikaa Pharmaceuticals, a Gujarat based healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ. "Troikaa is shortly to get US patent for its Dyanapar AQ 1 ml injections, as proceedings at the USFDA have got over, we are just awaiting certificate and confirmation from them (USFDA)," said Managing Director Troikaa Pharmaceuticals Ketan Patel.